Warfarin Potassium

华法林钾

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameWarfarin Potassium
Drug Alias Name华法令钾Warfarine PotassiqueWarfarinurn KalicurnKalii WarfarinumPotassium Warfarin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin K epOxide reductase complex subunit 1 inhibitors
TargetsVitamin K epOxide reductase complex subunit 1
Therapy Area/IndicationsVenous ThrombosisThromboembolismEmbolism +[6] 
Global Approved IndicationsVenous ThrombosisThromboembolismEmbolism +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1962/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSawai Pharmaceutical Co LtdEisai Co Ltd
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisThromboembolismEmbolism +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeB01AA03
Related LinksWikipediaDrugBankKEGG